These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27522374)

  • 21. [Ethical and social issues associated with genomic medicine].
    Barazzetti G; Kaufmann A; Benaroyo L
    Praxis (Bern 1994); 2014 May; 103(10):573-7. PubMed ID: 24800769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation.
    Chan S
    Regen Med; 2017 Oct; 12(7):839-851. PubMed ID: 29119870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Policy and ethical concerns in nanotechnology safety: case of Indian health sector.
    Anand M; Srivastava N; Sarma S
    J Biomed Nanotechnol; 2011 Feb; 7(1):34-5. PubMed ID: 21485790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards a bioethics of innovation.
    Lipworth W; Axler R
    J Med Ethics; 2016 Jul; 42(7):445-9. PubMed ID: 27015740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical challenges in rheumatology: a survey of the American College of Rheumatology membership.
    MacKenzie CR; Meltzer M; Kitsis EA; Mancuso CA
    Arthritis Rheum; 2013 Oct; 65(10):2524-32. PubMed ID: 23839952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The coming era of nanomedicine.
    Allhoff F
    Am J Bioeth; 2009 Oct; 9(10):3-11. PubMed ID: 19998074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occupational health practice and exposure to nanoparticles: reconciling scientific evidence, ethical aspects, and legal requirements.
    Franco G
    Arch Environ Occup Health; 2011; 66(4):236-40. PubMed ID: 22014197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping ethical and social aspects of cancer biomarkers.
    Blanchard A
    N Biotechnol; 2016 Dec; 33(6):763-772. PubMed ID: 27318010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanomedicine and society.
    Ferrari M; Philibert MA; Sanhai WR
    Clin Pharmacol Ther; 2009 May; 85(5):466-7. PubMed ID: 19381150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction to the article collection 'Translation in healthcare: ethical, legal, and social implications'.
    Morrison M; Dickenson D; Lee SS
    BMC Med Ethics; 2016 Nov; 17(1):74. PubMed ID: 27842524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regenerative medicine interventions for orthopedic disorders: ethical issues in the translation into patients.
    Niemansburg SL; van Delden JJ; Dhert WJ; Bredenoord AL
    Regen Med; 2013 Jan; 8(1):65-73. PubMed ID: 23259806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can Neuroscience Contribute to Practical Ethics? A Critical Review and Discussion of the Methodological and Translational Challenges of the Neuroscience of Ethics.
    Racine E; Dubljević V; Jox RJ; Baertschi B; Christensen JF; Farisco M; Jotterand F; Kahane G; Müller S
    Bioethics; 2017 Jun; 31(5):328-337. PubMed ID: 28503831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroscientists' everyday experiences of ethics: the interplay of regulatory, professional, personal and tangible ethical spheres.
    Brosnan C; Cribb A; Wainwright SP; Williams C
    Sociol Health Illn; 2013 Nov; 35(8):1133-48. PubMed ID: 23397962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating nanomedicine and imaging.
    Pérez-Medina C; Hak S; Reiner T; Fayad ZA; Nahrendorf M; Mulder WJM
    Philos Trans A Math Phys Eng Sci; 2017 Nov; 375(2107):. PubMed ID: 29038380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occupational exposure to nanomedical applications.
    Murashov V
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(2):203-13. PubMed ID: 20049791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From bench to bedside and to health policies: ethics in translational research.
    Petrini C
    Clin Ter; 2011; 162(1):51-9. PubMed ID: 21448547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The era of nanomedicine and nanoethics: has it come, is it still coming, or will it pass us by?
    Johnson S
    Am J Bioeth; 2009 Oct; 9(10):1-2. PubMed ID: 19998072
    [No Abstract]   [Full Text] [Related]  

  • 40. Nanomedicine: ethical concerns beyond diagnostics, drugs, and techniques.
    McGee EM
    Am J Bioeth; 2009 Oct; 9(10):14-5. PubMed ID: 19998076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.